What is LOPJLB’s current signal on DRTS?

LOPJLB’s latest quantitative signal on Alpha Tau Medical Ltd (DRTS) is SELL in a BEAR regime. Signals are updated daily.

What market regime is DRTS in?

Alpha Tau Medical Ltd (DRTS) is currently classified in the BEAR HMM market regime on LOPJLB.

What does Alpha Tau Medical Ltd (DRTS) do?

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical st…

Alpha Tau Medical Ltd (DRTS)

COMPARE

Healthcare · Biotechnology · NASDAQ · IL

$13.50-1.75%Close

SELLBEAR · day 10

Company news

globenewswire.com · 10d ago

Alpha Tau to Participate in October Investor Conferences

seekingalpha.com · 34d ago

Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More

seekingalpha.com · 41d ago

Alpha Tau: Approaching Massive Year-End; Pounding The Table On Potential GBM Breakthrough

globenewswire.com · 43d ago

Alpha Tau to Participate in September Investor Conferences

globenewswire.com · 45d ago

Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions

defenseworld.net · 63d ago

PAVmed (NASDAQ:PAVM) versus Alpha Tau Medical (NASDAQ:DRTS) Critical Contrast

globenewswire.com · 66d ago

Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

globenewswire.com · 86d ago

Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold for Success

defenseworld.net · 88d ago

Alpha Tau Medical (NASDAQ:DRTS) Trading 7.1% Higher – Here’s Why

globenewswire.com · 92d ago

Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center

Market news & ticker search · RSS for DRTS

FAQ

What is LOPJLB’s current signal on DRTS?: LOPJLB’s latest quantitative signal on Alpha Tau Medical Ltd (DRTS) is SELL in a BEAR regime. Signals are updated daily.
What market regime is DRTS in?: Alpha Tau Medical Ltd (DRTS) is currently classified in the BEAR HMM market regime on LOPJLB.
What does Alpha Tau Medical Ltd (DRTS) do?: Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical st…

Alpha Tau Medical Ltd (DRTS)

Key stats

Industry peers

Prediction markets

Company news

FAQ